Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth A Suarez

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Epidemiology (Cambridge, Mass.)|October 17, 2022
Monitoring Drug Safety in Pregnancy with Scan Statistics: A Comparison of Two Study DesignsElizabeth A Suarez, Michael Nguyen, Di Zhang, et al.
The New England Journal of Medicine|November 30, 2022
Buprenorphine versus Methadone for Opioid Use Disorder in PregnancyElizabeth A Suarez, Krista F Huybrechts, Loreen Straub, et al.
Alcohol, Clinical & Experimental Research|August 23, 2025
Discontinuation of treatment for alcohol use disorder during pregnancy and postpartum in the United StatesCaitlin E Martin, Jennifer K Bello, Bridget M Galati, et al.
JAMA Internal Medicine|October 3, 2022
Association of Antidepressant Use During Pregnancy With Risk of Neurodevelopmental Disorders in ChildrenElizabeth A Suarez, Brian T Bateman, Sonia Hernández-Díaz, et al.
JAMA Psychiatry|January 24, 2024
Prescription Stimulant Use During Pregnancy and Risk of Neurodevelopmental Disorders in ChildrenElizabeth A Suarez, Brian T Bateman, Sonia Hernandez-Diaz, et al.
Pharmacoepidemiology and Drug Safety|July 25, 2022
Novel methods for pregnancy drug safety surveillance in the FDA Sentinel SystemElizabeth A Suarez, Michael Nguyen, Di Zhang, et al.
JAMA Psychiatry|January 5, 2022
Neurodevelopmental Disorders Among Publicly or Privately Insured Children in the United StatesLoreen Straub, Brian T Bateman, Sonia Hernandez-Diaz, et al.
JAMA Internal Medicine|March 28, 2022
Association of Antipsychotic Drug Exposure in Pregnancy With Risk of Neurodevelopmental Disorders: A National Birth Cohort StudyLoreen Straub, Sonia Hernández-Díaz, Brian T Bateman, et al.
American Journal of Obstetrics & Gynecology MFM|February 3, 2025
Attention-deficit hyperactivity disorder medication discontinuation during pregnancy and resumption postpartumKevin Y Xu, Lisa M Pappas, Tashalee R Brown, et al.
Obstetrics and Gynecology|January 9, 2026
Psychostimulant Continuation and Postpartum Mental Health in Pregnant People With Attention-Deficit/Hyperactivity DisorderKevin Y Xu, Lisa M Pappas, Tashalee R Brown, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Epidemiology (Cambridge, Mass.)|October 17, 2022
Monitoring Drug Safety in Pregnancy with Scan Statistics: A Comparison of Two Study DesignsElizabeth A Suarez, Michael Nguyen, Di Zhang, et al.
The New England Journal of Medicine|November 30, 2022
Buprenorphine versus Methadone for Opioid Use Disorder in PregnancyElizabeth A Suarez, Krista F Huybrechts, Loreen Straub, et al.
Alcohol, Clinical & Experimental Research|August 23, 2025
Discontinuation of treatment for alcohol use disorder during pregnancy and postpartum in the United StatesCaitlin E Martin, Jennifer K Bello, Bridget M Galati, et al.
JAMA Internal Medicine|October 3, 2022
Association of Antidepressant Use During Pregnancy With Risk of Neurodevelopmental Disorders in ChildrenElizabeth A Suarez, Brian T Bateman, Sonia Hernández-Díaz, et al.
JAMA Psychiatry|January 24, 2024
Prescription Stimulant Use During Pregnancy and Risk of Neurodevelopmental Disorders in ChildrenElizabeth A Suarez, Brian T Bateman, Sonia Hernandez-Diaz, et al.
Pharmacoepidemiology and Drug Safety|July 25, 2022
Novel methods for pregnancy drug safety surveillance in the FDA Sentinel SystemElizabeth A Suarez, Michael Nguyen, Di Zhang, et al.
JAMA Psychiatry|January 5, 2022
Neurodevelopmental Disorders Among Publicly or Privately Insured Children in the United StatesLoreen Straub, Brian T Bateman, Sonia Hernandez-Diaz, et al.
JAMA Internal Medicine|March 28, 2022
Association of Antipsychotic Drug Exposure in Pregnancy With Risk of Neurodevelopmental Disorders: A National Birth Cohort StudyLoreen Straub, Sonia Hernández-Díaz, Brian T Bateman, et al.
American Journal of Obstetrics & Gynecology MFM|February 3, 2025
Attention-deficit hyperactivity disorder medication discontinuation during pregnancy and resumption postpartumKevin Y Xu, Lisa M Pappas, Tashalee R Brown, et al.
Obstetrics and Gynecology|January 9, 2026
Psychostimulant Continuation and Postpartum Mental Health in Pregnant People With Attention-Deficit/Hyperactivity DisorderKevin Y Xu, Lisa M Pappas, Tashalee R Brown, et al.
Pageof 5